135 related articles for article (PubMed ID: 1647952)
21. All prepro-VIP-derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen.
Skakkebaek ML; Georg B; Mikkelsen JD; Ottesen B; Fahrenkrug J
Peptides; 1995; 16(7):1287-94. PubMed ID: 8545253
[TBL] [Abstract][Full Text] [Related]
22. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization.
Bredkjaer HE; Wulff BS; Emson PC; Fahrenkrug J
Cell Tissue Res; 1994 May; 276(2):229-38. PubMed ID: 8020060
[TBL] [Abstract][Full Text] [Related]
23. Co-existence and co-secretion of the structurally related peptides VIP and PHI.
Fahrenkrug J
Scand J Clin Lab Invest Suppl; 1987; 186():43-50. PubMed ID: 3474771
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an alpha-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP).
Maltèse JY; Monge G; Giraud P; Salers P; Ouafik LH; Pelen F; Oliver C
Clin Endocrinol (Oxf); 1990 Oct; 33(4):467-80. PubMed ID: 2171816
[TBL] [Abstract][Full Text] [Related]
25. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin.
Yasuda M; Maeda K; Kakigi T; Minamitani N; Kawaguchi T; Tanaka C
Neuropeptides; 1995 Dec; 29(6):325-30. PubMed ID: 8837959
[TBL] [Abstract][Full Text] [Related]
26. Prepro-vasoactive intestinal polypeptide-derived peptide sequences in cerebral blood vessels of rats: on the functional anatomy of metabolic autoregulation.
Zhang ET; Mikkelsen JD; Fahrenkrug J; Møller M; Kronborg D; Lauritzen M
J Cereb Blood Flow Metab; 1991 Nov; 11(6):932-8. PubMed ID: 1939387
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).
Long RG; Bryant MG; Mitchell SJ; Adrian TE; Polak JM; Bloom SR
Br Med J (Clin Res Ed); 1981 May; 282(6278):1767-71. PubMed ID: 6786616
[TBL] [Abstract][Full Text] [Related]
28. Alternative processing pathways for preprovasoactive intestinal peptide in the enteric nervous system of the rat.
Dimaline R; Vowles L
Regul Pept; 1988 Mar; 20(3):199-210. PubMed ID: 3240339
[TBL] [Abstract][Full Text] [Related]
29. Infusion of prepro-VIP derived peptides in man: effect on secretion of prolactin.
Yiangou Y; Gill JS; Chrysanthou BJ; Burrin J; Bloom SR
Neuroendocrinology; 1988 Dec; 48(6):615-8. PubMed ID: 3251160
[TBL] [Abstract][Full Text] [Related]
30. Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response.
Yiangou Y; Serrano R; Bloom SR; Peña J; Festenstein H
J Neuroimmunol; 1990; 29(1-3):65-72. PubMed ID: 2170441
[TBL] [Abstract][Full Text] [Related]
31. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract.
Palle C; Ottesen B; Jørgensen J; Fahrenkrug J
Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870
[TBL] [Abstract][Full Text] [Related]
32. Glycine-extended processing intermediate of proVIP: a new form of VIP in the rat.
Fahrenkrug J
Biochem Biophys Res Commun; 1991 Jul; 178(1):173-7. PubMed ID: 2069556
[TBL] [Abstract][Full Text] [Related]
33. Isolation, characterization, and pharmacological actions of peptide histidine valine 42, a novel prepro-vasoactive intestinal peptide-derived peptide.
Yiangou Y; Di Marzo V; Spokes RA; Panico M; Morris HR; Bloom SR
J Biol Chem; 1987 Oct; 262(29):14010-3. PubMed ID: 3654650
[TBL] [Abstract][Full Text] [Related]
34. Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42).
Cauvin A; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
Endocrinology; 1989 Nov; 125(5):2645-55. PubMed ID: 2792003
[TBL] [Abstract][Full Text] [Related]
35. Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine.
Tse DL; Pang RT; Wong AO; Chan SM; Vaudry H; Chow BK
Endocrinology; 2002 Apr; 143(4):1327-36. PubMed ID: 11897689
[TBL] [Abstract][Full Text] [Related]
36. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells.
Wershil BK; Turck CW; Sreedharan SP; Yang J; An S; Galli SJ; Goetzl EJ
Cell Immunol; 1993 Oct; 151(2):369-78. PubMed ID: 8402943
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
38. Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin.
Yasuda M; Minamitani N; Maeda K; Chihara K; Fujita K; Kobayashi I
Regul Pept; 1993 Jul; 46(3):565-73. PubMed ID: 8210516
[TBL] [Abstract][Full Text] [Related]
39. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
40. Vascular effects and cyclic AMP production produced by VIP, PHM, PHV, PACAP-27, PACAP-38, and NPY on rabbit ovarian artery.
Yao W; Sheikh SP; Ottesen B; Jørgensen JC
Peptides; 1996; 17(5):809-15. PubMed ID: 8844771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
